The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Brian Giswali - Raymond James - Analyst
: <_ALACRA_META_ABSTRACT>John, I want to maybe start off with just level setting the audience to who CACI is how the business has really transformed because
I think there's a really significant transformation element to what the business is today versus what it was 10 or 15 years ago.
Question: Brian Giswali - Raymond James - Analyst
: So we're at the chocolate and peanut butter phase.
Question: Brian Giswali - Raymond James - Analyst
: Okay. Perfect. Let's zoom out a question that's been on the just about every investor's mind that I've talked to are going to be a little
bit more macro in nature before we drill down. Help us with the defense budget and what's going on in DC, you reconcile the 8%
decline Hegseth calls for, the house bill that calls for incremental defense spending and substantial increases and then really what
we're going to do with the shutdown coming up here as congress negotiates over the next couple of weeks.
Question: Brian Giswali - Raymond James - Analyst
: Really helpful color there. Let's pivot into DOGE, I know a lot of you in the room have fatigue, John, I'm sure you have a little DOGE
fatigue. I think it's natural at 75 days post election here. But I want to stick away from the philosophy of DOGE and really talk about
as you did a deep dive on your contract base.
Has anything been shut down from a contract standpoint and are things that you're considerably worried about. Given your national
security footprint, I wouldn't imagine there's very much of anything.
Question: Brian Giswali - Raymond James - Analyst
: I'll let them speak but that's exactly the way I had expected the answer and really appreciate the color. Let's maybe double-click on
some metrics and talk about some opportunities here, right? You replenished your pipeline last quarter. This, I think, is indicative of
how you've targeted and segmented the market and proactively bid on stuff early. So maybe talk about that and what that creates
for you?
Question: Brian Giswali - Raymond James - Analyst
: That's a great segue into, let's talk a little bit more about backlog. Most investors I talk with look at backlog as a leading indicator to
future growth that 1.0 book-to-bill or growing backlog is critical for investor psyche your backlog is up 10%. Are you going to grow
be able to grow backlog given the pipeline and all the noise out there over the next 12 months?
Question: Brian Giswali - Raymond James - Analyst
: That's the calendar is a little bit in your favor, too, right? We've been pretty conditioned to seeing strong September year-end, right?
So I think you do benefit a little bit from that. I want to pivot to organic growth now. You're guiding a really robust 7% to 10% this
year. And it seems like you've discussed having an awful lot of visibility in that number, via backlog and awards and pipeline and
everything else.
The stock has languished though, and I believe there is a large group of investors that believe CACI and the rest of the sector is going
to compress. I don't share that view, and I don't think you do. Can you talk about your organic growth and how confident you are
in that three-year guide that you put out at your Analyst Day?
Question: Brian Giswali - Raymond James - Analyst
: Absolutely. I appreciate that. And so lots of visibility, you're going to grow your position where you want to be. Maybe one thing on
comparing and addressing current CACI with the current budget with a historical reference point. I think a lot of folks are looking
to sequestration as the guide. I don't think that's the best example. And I think it's also not the same CACI that went through
sequestration. Maybe just put a finer point on how you're thinking about history, current CACI and current conditions.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MARCH 04, 2025 / 4:00PM, CACI.N - CACI International Inc at Raymond James Institutional Investors
Conference
Question: Brian Giswali - Raymond James - Analyst
: That's great. That's all the time we have for today. John and Jeff are going to join us in the breakout session. I'm sure there's going
to be a lot more interesting discussion to go. Thanks for taking the hard questions head on.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MARCH 04, 2025 / 4:00PM, CACI.N - CACI International Inc at Raymond James Institutional Investors
Conference
|